STEPHEN PAPPAS

Concepts (66)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Hepatorenal Syndrome
12
2025
31
2.700
Why?
Vasoconstrictor Agents
11
2025
137
1.180
Why?
Lypressin
9
2025
18
0.940
Why?
Hepatitis B
1
2021
172
0.620
Why?
Duty to Warn
1
2019
2
0.590
Why?
Professional Impairment
1
2019
3
0.590
Why?
Alcoholic Intoxication
1
2019
13
0.580
Why?
Confidentiality
1
2019
105
0.550
Why?
Hepatitis C Antibodies
1
2017
26
0.540
Why?
Kidney Function Tests
2
2017
135
0.530
Why?
Alcoholism
1
2019
244
0.490
Why?
Diagnostic Tests, Routine
1
2017
130
0.490
Why?
Hepacivirus
1
2017
273
0.470
Why?
Albumins
6
2023
89
0.430
Why?
Liver Cirrhosis
5
2023
908
0.230
Why?
Acute Kidney Injury
2
2025
684
0.230
Why?
Bradycardia
1
2025
57
0.220
Why?
Liver Transplantation
3
2023
1132
0.200
Why?
Respiratory Insufficiency
2
2022
240
0.190
Why?
Hepatitis, Alcoholic
1
2023
29
0.190
Why?
Hepatitis B Antibodies
1
2021
24
0.180
Why?
Arrhythmias, Cardiac
1
2025
483
0.170
Why?
Hepatitis B Vaccines
1
2021
49
0.170
Why?
Acute-On-Chronic Liver Failure
1
2022
73
0.170
Why?
Hepatitis B virus
1
2021
137
0.160
Why?
Liver Cirrhosis, Alcoholic
1
2019
40
0.150
Why?
Safety
1
2019
214
0.140
Why?
Hepatic Encephalopathy
1
2019
82
0.140
Why?
Humans
16
2025
130574
0.130
Why?
Drug Therapy
1
2017
83
0.130
Why?
Health Personnel
1
2021
547
0.120
Why?
Alcohol Drinking
1
2019
346
0.120
Why?
Self Report
1
2019
557
0.120
Why?
Patient Education as Topic
1
2019
456
0.110
Why?
Interdisciplinary Communication
1
2016
133
0.110
Why?
Systemic Inflammatory Response Syndrome
1
2016
204
0.110
Why?
Surgical Procedures, Operative
1
2017
226
0.110
Why?
Interprofessional Relations
1
2016
149
0.110
Why?
Hepatitis C
1
2017
388
0.100
Why?
Information Dissemination
1
2016
195
0.100
Why?
Metabolomics
1
2017
500
0.100
Why?
Gastrointestinal Diseases
1
2016
339
0.090
Why?
Clinical Trials, Phase III as Topic
2
2025
76
0.090
Why?
Disease Progression
1
2017
2201
0.090
Why?
Renal Replacement Therapy
2
2023
162
0.080
Why?
Treatment Outcome
6
2023
12891
0.080
Why?
Biomarkers
1
2019
3397
0.070
Why?
Physicians
1
2016
636
0.070
Why?
Double-Blind Method
2
2021
1625
0.060
Why?
Randomized Controlled Trials as Topic
2
2025
1246
0.060
Why?
Middle Aged
6
2025
28448
0.060
Why?
Canada
2
2016
326
0.060
Why?
Drug Therapy, Combination
2
2017
1165
0.050
Why?
Infusions, Intravenous
1
2021
546
0.040
Why?
Male
6
2025
64557
0.040
Why?
Female
6
2025
70509
0.040
Why?
Aged
3
2025
20925
0.040
Why?
Combined Modality Therapy
1
2021
1234
0.030
Why?
Placebos
1
2016
226
0.030
Why?
Survival Rate
1
2020
2136
0.030
Why?
Adult
3
2025
31202
0.030
Why?
Survival Analysis
1
2016
1509
0.020
Why?
Prognosis
1
2020
4927
0.020
Why?
Kidney
1
2016
1283
0.020
Why?
United States
1
2016
11820
0.010
Why?
Retrospective Studies
1
2016
17653
0.010
Why?
PAPPAS's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (66)
Explore
_
Co-Authors (4)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_